Consequently, NDR1 and FBXO11 collaboratively regulate β-catenin activity in prostate cancer cells through a mechanism of dual phosphorylation-driven ubiquitination, potentially suppressing EMT (Xuan et al., 2024). Here, FBXO11 is linked to prostate carcinoma.